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INTRODUCTION 
 
Mushrooms have been appreciated for their flavors, economic value, ecological value, and 
medicinal properties for many years [1]. Many therapeutic effects have been reported for medicinal 
mushrooms such as anti-inflammatory [2], antitumor [3-5], anticancer and immunomodulatory 
effects [6-7]; stimulating macrophage activity and anti-hepatitis B virus activity [8]; and anti-
oxidative activities [9-12]. Phellinus linteus (P. linteus) and Phellinus igniarius (P. igniarius) (L.) 
Quel. are basidiomycetous fungi belonging to the Hymenochaetaceae. Extracts of both were found 
to have anti-inflammatory activity in vitro as well as in vivo [13-16]. P. igniarius is a rich source of 
secondary metabolites like triterpenoids and polyphenols [17]. 
Polyphenol containing extracts from P. igniarius were found to be strongly anti-oxidant 
[18-21]. Little or no attention has ever been paid to their effects on stroke, which is a 
neurodegenerative disorder in whose pathogenesis reactive oxygen species (ROS) [22] such as 
superoxide anion radical (O2
•‒
), hydrogen peroxide (H2O2), and hydroxyl radical (•OH) play an 
important role. Oxidative stress might be pathogenic at the early stage in the disease, and it can 
exacerbate it during later stages.  
Iodoacetic acid (IAA) is an alkylating agent that reacts with cysteine residues of proteins. It 
is an irreversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which is an 
enzyme of the glycolytic pathway. It was reported that IAA-treated neuronal cells die following 
depletion of intracellular ATP, mitochondrial dysfunction, and production of reactive oxygen 
species (ROS) [23-26]. These observations are similar with those of in vivo ischemic stroke [23]. 
Acrolein is a common environmental pollutant that is associated with respiratory disease, 
aberrant platelet aggregation and increased thrombosis [27]. Kazuei Igarashi’s group suggested that 
the toxicity of acrolein (CH2=CHCHO) is more severe than that of H2O2 and nearly equal to that of 
•OH [28]. Acrolein is spontaneously formed from spermidine and spermine by amine oxidase [29]. 
Once cells are damaged, polyamines are released from RNA [30], and acrolein is produced by 
polyamine oxidizing enzymes. Acrolein is toxic and will cause further cell damage and increase the 
levels of protein-conjugated acrolein (PC-Acro) as observed in stroke [31]. Furthermore, Igarishi’s 
group presented that the toxicity of H2O2 was reduced by polyphenols [32]. Based on this we have 
investigated the effect of polyphenol extract from P. igniarius, and it prevented toxicity from 
acrolein and ROS in FM3A cells, Neuro-2a cells and photo-induced thrombosis model mice. 
Furthermore, we identified P. igniarius polyphenols by liquid chromatography mass spectrometry 
(LCMS) and proton nuclear magnetic resonance spectroscopy (NMR). 
Polysaccharide extracts from fruiting bodies of several mushroom species have shown 
various biological activities such as free radical scavenging activity [33], antitumor activity [34], 
anti-inflammatory activity [35] and they have successfully been used in immunochemotherapy of 
cancer in Japan [36]. A major polysaccharide component of mushrooms is cell wall derived 
(1→3;1→6)-β-D-polysaccharide [37-39], of which the most common biological effect is 
immunomodulation [40-41].  
  Toll-like receptors (TLRs) and C-type lectin receptors (CLRs) are known to trigger pro-
inflammatory immune responses [42]. CLRs specifically bind to glycans, such as mannans, 
GlcNAc, GalNAc, lNAc, and glucans from different mushrooms that all have a different structure 
and conformation and could induce different immunomodulatory effects [43-47].   
 
 
2 
 
  Lipopolysaccharide (LPS) is an endotoxin consisting of a lipid-carbohydrate component 
from the outer membrane of gram-negative bacteria, such as E. coli. LPS is recognized by TLR4 
which activates the innate immune system and promotes the secretion of proinflammatory 
cytokines including tumor necrosis factor (TNF-α) by monocytes and macrophages [48]. In 
addition, TNF-α is often induced together with Interleukin-6 (IL-6) that plays a major regulatory 
role in acute local and systemic inflammatory responses such as those elicited by either local lung 
or systemic exposure to endotoxin [49]. IL-6 is thought to have both pro- and anti-inflammatory 
effects. In the background of obesity and insulin resistance a low and persistent level of chronic 
inflammation can be found with IL-6 as one of the suggested mediators [50]. IL-6 has been 
implicated in the release of triglycerides and free fatty acids, downregulation of lipoprotein lipase, 
insulin resistance, and increased production of reactive oxygen species and decreased nitric oxide 
generation [50]. Interleukin-10 (IL-10) is a monokine that is not only produced in monocytes and 
macrophages but also in Th1 cells, B cells and Tr1 cells [51-55]. IL-10 plays a suppressing role in 
inflammatory responses. It downregulates the expression of TNF-α in monocytes and macrophages. 
IL-6 and TNF-α cytokines induced by LPS were both found significantly inhibited by IL-10 in 
macrophage cell lines [56] In this manuscript, the structure and composition of (1→3; 1→6)-β-D-
polysaccharides from P. linteus and P. igniarius were studied by HPLC, GC-MS and NMR (1-H, 
13-C, COSY, NOESY and TOCSY). Furthermore, the effects of (1→3; 1→6)-β-D-polysaccharides 
were examined on the production of IL-6, IL-10 and TNF-α by the Abelson leukemia virus 
transformed monocyte/macrophage cell line (RAW 264.7) that was treated by LPS.  
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RESULTS AND DISCUSSION 
CHAPTER 1 
Characterization and identification of polyphenol extracts from  
Phellinus linteus and Phellinus igniarius 
 
P. linteus and P. igniarius are well-known fungal species of the genus Phellinus from the 
Hymenochaetaceae family which has been used as a source of traditional herbal medicine in 
oriental countries such as China, Korea, and Japan for many years (Fig. 1). P. linteus extract was 
reported to has anti-angiogenic, anti-oxidant [57-58], anti-inflammation [59], anti-cancer [60] and 
anti-bacteria effect [61]. It was reported earlier that hispolon, a phenolic compound from P. linteus 
has anti-inflammatory, anti-proliferative and anti-metastatic effects [62]. P. igniarius was also 
reported that has Antiproliferative and antimetastatic effects [63], anti-tumor effect [64], 
Antioxidant activity [65] and anti-influenza virus effect [66]. The group of phenolic compounds 
offers several bioactivities such as anti-oxidant effects [67-68], DPPH radical-scavenging capacity 
[69] and tyrosinase inhibition [70].  
Therefore, we undertook the analysis of the DMSO soluble fraction of the P.linteus and P. 
igniarius ethanol extract followed by electron spray ionization LC-MS. The characterization of P. 
linteus polyphenols was confirmed by proton nuclear magnetic resonance spectroscopy (NMR). 
This study describes the difference in polyphenol composition of these tightly related Phellinus 
species. Whether this difference could be responsible for the intriguing difference in biological 
activity remains to be solved. 
 
 
 
Fig. 1. Phellinus linteus and Phellinus igniarius 
 
1.1. Total Phenolics Determination 
 
The crude polyphenol extract were measured by the Folin-Ciocalteau method and UV 
absorbance polyphenol index (750 nm) as reference values, with highly significant correlation 
coefficients of antioxidant effect for 0.9946 by the range of gallic acid from 0 to 500 µg/ml (Fig. 2). 
The DMSO fraction from P. linteus and P. igniarius contained 458.73 μg and 323.08 phenol μg per 
ml respectively. The water extract from P. linteus and P. igniarius contained 20.18 μg and 55.82 μg 
phenol per ml respectively indicating that crude polyphenol extract has 23 and 6 times respectively 
more antioxidant effect than the crude water extract by Folin-Ciocalteau assay. 
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Fig. 2. The coefficients of antioxidant effect by the range of gallic acid from 0 to 500 µg/ml. 
 
1.2 Analysis of polyphenols by liquid chromatography mass spectrometry (LC-MS) 
 
1.2.1 Analysis of polyphenols from Phellinus linteus by LC-MS 
 
The total ion current (TIC) chromatogram of the polyphenol extract from P. linteus showed 
10 main peaks (Fig. 3). The composition of the chromatograms was analyzed by MASS++ with the 
MassBank library. To confirm identification, the compounds were identified by comparing their 
retention time and mass spectral data (Fig. 4). The ESI-MS of compound 1 gave a molecular ion at 
m/z 136.84 [M−H]− at 25.0 min (Fig. 4A) whereas the ESI-MS of 3,4-Dihydroxybenzaldehyde 
gave a molecular ion at m/z 136.90 [M−H]− at 23.9 min (Fig. 5). The molecular formula of 
compound 1 was determined as C7H6O3 by 
1
H NMR spectral data of 3,4-Dihydroxybenzaldehyde 
(Fig. 6) (Suabjakyong et al., 2015). This strongly suggested that compound 1 is 3,4-
Dihydroxybenzaldehyde (Table 1). 
 
 
Fig. 3. Total ion current (TIC) chromatogram of polyphenols from P. linteus. The peak numbers are 
the same as in Table 1. 
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Fig. 4. ESI-MS spectra of P. linteus polyphenols from compounds 1-10 (A-J). 
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Fig. 5. Chromatogram and ESI-MS spectra of 3,4-dihydroxybenzaldehyde. 
 
 
 
Fig. 6. 
1
H 600 NMR spectra of 3,4-dihydroxybenzaldehyde in DMSO-d6 with TMS at 25ºC. 
 
The ESI-MS of compound 2 gave a molecular ion at m/z 176.84 [M−H]− at 34.9 min (Fig. 
3B). The ESI-MS of Esculetin and 4-(3,4-Dihydroxyphenyl-3-buten-2one gave a molecular ion at 
m/z 176.75 at 23.9 min (Fig. 6) and 177 [M−H]− [71] respectively. 4-(3,4-Dihydroxyphenyl-3-
buten-2one has one more carbon atom than Esculetin. It was tentatively suggested that compound 2 
is 4-(3,4-Dihydroxyphenyl-3-buten-2one. The ESI-MS of compound 3 gave a molecular ion at m/z 
463.10 [M−H]−. Weesepoel (2009) suggested that compound 3 might be Davallialactone or 
Interfungin A. Proton NMR resonances of compound 3 showed strongly signals of Interfungin A 
[72] that lack signals of Davallialactone as shown in Table 2. These observations strongly suggest 
that compound 3 is Interfungin A. The ESI-MS of compound 8 gave a molecular ion at m/z 377.05 
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[M−H]−. Weesepoel (2009) suggested compound 8 might be Inoscavin E or Phellifuropyranone A. 
In 2013, Yoon & Paik (2013) showed that P. linteus extract contains Inoscavin E [73]. Furthermore, 
the proton NMR resonances of compound 8 showed strongly signals of Inoscavin E [74] as shown 
in Table 3. It was strongly suggested that compound 8 is Inoscavin E. 
 
 
 
 
 
Fig. 7. Chromatogram and ESI-MS spectra of Esculetin. 
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Table 1. Tentative identification of polyphenol extract from Phellinus linteus by UPLC/ESI-MS in 
negative  
 
Compounds RT 
(min) 
Tentative identification MW [M-H]
-
 
m/z 
UPLC/ESI-MS (% base peak) 
1 25.0 3,4-
dihydroxybenzaldehyde 
138.12 136.84 136.84(100), 250.79(21.69), 
282.89(20.29), 256.03(7.92), 
261.81(6.87), 263.81(5.24) 
2 34.9 4-(3,4-dihydroxyphenyl-
3-buten-2one 
178.19 176.84 176.84(100), 290.91(21.86), 
363.11(9.73), 355.10(8.08), 
310.96(5.56) 
3 42 Interfungin A 464.43 463.10 463.10(100), 431.05(26), 
391.06(22.47). 
365.05(21.48), 
433.09(12.40), 379.12(7.24), 
827.55(6.81), 438.95(6.51), 
423.06(6.05) 
4 49.0 Inonoblin C 462.42 461.07 461.07(100) 
5 50.1 Inonoblin C 462.42 461.07 461.07(100) 
6 52.2 Phelligridin D 380.31 379.01 379.01(100) 
7 53.6 Interfungin B 422.40 421.04 421.04(100), 379.03(24.40), 
317.02(11.79), 377.07(6.00), 
323.08(5.70), 457.04(5.67), 
354.85(5.64) 
8 55.1 Inoscavin E 378.34 377.05 377.05(100), 491.08(36.29), 
329.21(8.16), 161.55(5.68), 
300.46(5.34) 
9 55.9 Inoscavin C 420.38 419.05 419.05(100) 
10 60.9 Methylinoscavin D 410.38 409.05 409.05(100), 329.00(15.75), 
248.81(12.94), 403.07(9.63), 
479.07(5.75), 467.00(5.37) 
 
 
1.2.2  Analysis of polyphenols from P. igniarius by LC-MS 
 
The total ion current (TIC) chromatogram of the ethanol extract from P. igniarius showed 
main 9 peaks (Fig. 8). The composition of the chromatograms was analyzed by MASS++ with 
MassBank library. To confirm identification, the compounds were identified by comparing their 
retention time and mass spectral data (Fig. 9). The ESI-MS of compound 1 gave a molecular ion at 
m/z 136.89 [M−H]− at 24.0 min (Fig. 9A) that ESI-MS of 3,4-Dihydroxybenzaldehyde gave a 
molecular ion at m/z 136.90 [M−H]− at 23.9 min (Fig. 5). The molecular formula of compound 1 
was determined as C7H6O3 by 
1
H NMR spectral data of 3,4-Dihydroxybenzaldehyde (Fig. 6). This 
strongly suggested that compound 1 is 3,4-Dihydroxybenzaldehyde (Table 2). 
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The ESI-MS of compound 2 gave a molecular ion at m/z 176.81 [M−H]− at 33.8 min (Fig. 
9B). The ESI-MS of Esculetin and 4-(3,4-Dihydroxyphenyl-3-buten-2one gave a molecular ion at 
m/z 176.75 at 23.9 min (Fig. 7) and 177 [M−H]− [71] respectively. 4-(3,4-Dihydroxyphenyl-3-
buten-2one has one more carbon atom than Esculetin. It was tentatively suggested that compound 2 
is 4-(3,4-Dihydroxyphenyl-3-buten-2one. Compound 3 to 7 and 9 were tentative identified by 
masses of the corresponding [M−H]− from the M.Sc thesis of Weesepoel [71]. 
 
 
 
 
Fig. 8. Total ion current (TIC) chromatogram of polyphenols from P. igniarius. 
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Fig. 9. ESI-MS spectra of P. igniarius polyphenols from compounds 1-10 (A-J). 
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Table 2. Tentative identification of polyphenol extract from P. igniarius by UPLC/ESI-MS in 
negative  
Compounds RT 
(min) 
Tentative identification MW [M-H]
-
 
m/z 
UPLC/ESI-MS (% base peak) 
1 23.8 3,4-
dihydroxybenzaldehyde 
138.12 136.81 136.81(100), 274.86(14.27), 
342.94(5.98) 
2 33.8 4-(3,4-
dihydroxyphenyl-3-
buten-2one 
178.19 176.81 176.81(100), 355.01(16.71) 
3 48.0 inonoblin C 462.42 461.07 461.07(100), 196.79(6.10) 
4 49.1 inonoblin C 462.42 461.07 461.07(100), 196.79(6.10) 
5 51.2 phelligridin D 380.31 378.98 378.98(100), 492.97(6.69) 
6 55.2 inoscavin C 420.38 419.06 419.06(100), 310.98(11.18), 
758.17(2.60), 454.98(6.93), 
847.25(6.49), 
 453.07(6.48), 375.01(6.34), 
411.10(5.83), 459.04(5.77), 
381.07(5) 
7 56.7 phelligridin C 364.31 363.01 363.01(100), 379.00(5.57) 
8 60 unknown n.d. 262.95 262.95(100), 571.02(15.03), 
218.93(14.74), 360.98(13.51), 
321.02(12.51), 419.05(9.56), 
385.95(8.05), 359.11(7.97), 
343.06(7.10),379.00(6.56), 
250.91(6.46), 364.97(5.78), 
751.02(5.76) 
9 64.7 interfungin B 422.40 421.12 421.12(100), 431.14(66.72), 
459.08(9.10), 248.92(8.02), 
265.03(6.06), 475.23(5.78), 
771.24(5.77) 
10 69.9 unknown n.d. 246.90 246.90(100), 315.02(15.50), 
871.16(9.39), 305.09(7.68), 
433.05(5.47), 359.18(5.39), 
309.01(5.07) 
 
3.3. Nuclear magnetic resonance spectroscopy (NMR) 
 
All polyphenol compounds were tentatively identified by masses of the corresponding 
[M−H]− from the M.Sc thesis of Weesepoel (2009) [71]. The assignment of proton NMR 
resonances in polyphenols from P. linteus indicated the presence of Inonoblin C [75] (compound 4 
and 5), Phelligridin D [75] (compound 6) and Inoscavin C [76] (compound 9) in Table 3. 
Furthermore, Furthermore, 
1
H NMR resonances of polyphenols from P. igniarius were assigned, 
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identifying Inonoblin C [75] (compounds 3 and 4), Phelligridin D [75] (compound 5), Inoscavin C 
[76] (compound 6) and Phelligridin C [76] (compound 7) in Table 4. 
 
Table 3. Compounds identified in polyphenol extract from Phellinus linteus by assignment of their 
proton resonances 
 
Compound 
1
H NMR chemical shifts and their assignments 
3,4-Dihydroxybenzaldehyde (1) 9.699 s, 6.918 s, 6.905 s, 7.273 d (2.06), 7.259 d (2.06), 7.236 d 
(2.06) 
Interfungin A (3) 
 
 
Inonoblin C (4),(5) 
6.235 s, 6.693 d (17.18), 7.383 d (17.18), 7.062 d (2.06), 6.813 
d (8.25), 7.012 dd (8.25, 2.06), 6.931 d (2.06), 6.686 d (8.25), 
6.839 d (8.25), 7.727 s, 7.051 s 
6.176 s, 6.693 d (17.18), 7.297 d (17.18), 7.062 d (2.06), 6.732 
d (8.25), 7.012 dd (8.25, 2.06), 6.820 s, 7.099 s, 6.319 brd 
(2.06), 2.273 s (Me) 
Phelligridin D (6) 6.725 s, 7.534 s, 8,351 s, 6.693 d (17.18), 7.297 d (17.18), 7.062 
d (2.06), 6.732 d (8.25), 7.012 dd (8.25, 2.06) 
Inoscavin E (8) 
 
 
Inoscavin C (9) 
6.962 s, 6.832 s, 7.236 d (2.06), 6.839 d (8.25), 7.266 dd (8.25, 
2.06), 6.70 d (17.18), 7.297 d (17.18), 7.062 d (2.06), 6.745 d 
(8.25), 7.012 dd (8.25, 2.06) 
6.846 s, 6.734 s, 7.072 s, 7.236 d (2.06), 6.839 d (8.25) 
 
 
Table 4. Compounds identified in polyphenol extract from Phellinus igniarius by assignment of 
their proton resonances 
 
Compound 
1
H NMR chemical shifts and their assignments 
3,4-Dihydroxybenzaldehyde (1) 9.702 s, 6.923 s, 6.909 s, 7.284 d (2.06), 7.270 d (2.06), 7.242 d 
(2.06) 
Inonoblin C (3),(4) 6.161 s, 6.690 d (17.18), 7.330 d (17.18), 6.985 d (2.06), 6.751 
d (8.25), 7.009 dd (8.25, 2.06), 6.816 s, 7.091 s, 6.260 brd 
(2.06), 2.280 s (Me) 
Phelligridin D (5) 6.730 s, 7.539 s, 8,361 s, 6.690 d (17.18), 7.330 d (17.18), 7.068 
d (2.06), 6.789 d (8.25), 7.009 dd (8.25, 2.06) 
Inoscavin C (6) 6.816 s, 6.758 s, 7.091 s, 7.242 d (2.06), 6.847 d (8.25) 
Phelligridin C (7) 6.730 s, 7.539 s, 8,361 s, 6.909 s, 6.847d (8.25) 
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CHAPTER 2 
Bioloigical activities of polyphenol extracts from 
Phellinus linteus and Phellinus igniarius 
 
2.1 The protection of polyphenol extracts on acrolein and H2O2 in in vitro 
 
To characterize the effects of PI EtOH extract on acrolein treated FM3A cells we first 
determined the possible cytotoxicity of PI EtOH extract by trypan blue assay. The extract showed 
no cytotoxicity at concentrations of 2, 1 and 0.5 µg/ml and only very slight cytotoxicity at 5 µg/ml. 
The cell toxicity caused by 5 (Fig. 10A) and 2 µM (Fig. 10B) acrolein was strongly 
prevented by 5 µg/ml PI EtOH extract and also prevented by a lower concentration of PI EtOH 
extract (Fig. 11). Cell toxicity caused by 100 µM H2O2 was prevented by 5 µg/ml PI EtOH extract 
(Fig. 10C), and it was also prevented by 0.5 µg/ml PI EtOH extract (Fig. 10D). PI EtOH extract 
strongly prevented the effects acrolein and to a higher extent than the effects of H2O2. The results 
suggest that the reactivity between •OH and PI EtOH extract may be relatively weak compared with 
the reactivity between acrolein and PI EtOH extract where strong prevention was observed. 
 
 
Fig. 10. The cytotoxicity of acrolein and H2O2 in FM3A cells. The viable cell number of FM3A 
cells that were treated with PI EtOH extract at 5 µg/ml plus acrolein at 5 µM (A) or 2 µM (B) or 
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100 µM H2O2 and cultured for 24 and 48 hrs. The number of cells was counted with 0.25% trypan 
blue. Each value represents the mean ± SD (n=3). 
 
 
Fig. 11. The cytotoxicity of acrolein in FM3A cells. The viable cell number of FM3A cells that 
were treated with PI EtOH extract at 0.5 µg/ml plus acrolein at 5 µM (A) or 2 µM (B) and cultured 
for 24 and 48 hrs. The number of cells was counted with 0.25% trypan blue. Each value represents 
the mean ± SD (n=3). 
 
 
 
Fig. 12. The cytotoxicity of H2O2 in FM3A cells. The viable cell number of FM3A cells that were 
treated with PI EtOH extract at 5 µg/ml plus 200 µM (A) or 100 µM (B) H2O2 and cultured for 24 
and 48 hrs. The number of cells was counted with 0.25% trypan blue. Each value represents the 
mean ± SD (n=3). 
 
We therefore undertook to measure the cytotoxicity of acrolein and iodoacetic acid in 
Neuro-2a cells instead of the solid tumor derived FM3A cells. The results showed that PL and PI 
crude aqueous extracts may protect cultured Neuro-2a cells, i.e., the number of cells at the end of 
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the incubation period, from the deleterious effects of being pretreated with 8 µM acrolein or 5 µM 
iodoacetic acid, respectively, for 4 hrs. PL ethanol extract may allow cells to recover after a 
pretreatment with 5 µM iodoacetic acid for 4 hrs (Fig. 13). In Fig. 14, it is shown that crude 
polysaccharide extract from P. linteus and P. igniarius provided no protection against iodoacetic 
acid. On the other hand, 0.5 µM PI EtOH extract and PI- and PL-derived polysaccharide extracts 
can protect cells from the toxic effects of 8 µM acrolein for 24 hrs (Fig. 14). These results strongly 
suggest that PI- and PL-derived extracts can protect Neuro-2a cells from acrolein cytotoxicity. 
 
 
Fig. 13. The effect of P. igniarius and P. linteus extracts on the cytotoxicity of acrolein and 
iodoacetic acid. The viable cell number of Neuro-2a cells that were treated with PI (A) or PL (B) 
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DDW crude extract at 20, 50, 100 and 200 µg/ml after a pretreatment with 8 µM acrolein for 4 hrs. 
PI (C) and PL (D) DDW crude extract at 20, 50, 100 and 200 µg/ml after a pretreatment with 5 µM 
iodoacetic acid for 4 hrs. PL EtOH crude extract (E) at 2, 5, 10, 20 and 50 µg/ml after a 
pretreatment with 5 µM iodoacetic acid for 4 hrs. Cell viability was determined by MTT assay after 
24 hrs. Each value represents the mean ± SD (n=3).  
 
 
 
Fig. 14. Effect of pretreatment of Neuro-2a cells with PL and PI extracts on cytotoxicity of acrolein. 
The viable cell number of Neuro-2a cells that were treated with PI EtOH crude extract (A) at 2, 5, 
10, 20 and 50 µg/ml, PI (B) or PL (C) DDW crude extract at 20, 50, 100 and 200 µg/ml for 4 hrs 
and treated with 8 µM acrolein. Cell viability was determined by MTT assay after 24 hrs. Each 
value represents the mean ± SD (n=3). 
 
We then did a time study, which is shown in Figs. 14 and 15. Crude polysaccharides of P. 
linteus and P. igniarius at 10, 20, 50 and 100 µg/ml, PI ethanol extract dissolved in water at 10, 20, 
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50 and 100 µg/ml and PI ethanol extract dissolved in DMSO at 0.5, 1, 2 and 5 µg/ml were tested on 
Neuro-2a cells with acrolein at 2, 5, and 10 µM for 12, 24 and 48 hrs. 
 
 
Fig. 15. Matrix assay of ethanol extract. EtOH extract dissolved in DMSO at 0.5, 1 and 2 µg/ml 
with acrolein at 2 µM (A); glucans of PI at 20 and 50 µg/ml and polysaccharides of PL at 10, 20 
and 50 µg/ml with acrolein at 2 µM (B); PI ethanol extract dissolved in DDW at 10, 20 and 50 
µg/ml with acrolein at 2 µM (C) or 5 µM (D). Cell viability was determined by MTT assay after 12, 
24 and 48 hrs. Each value represents the mean ± SD (n=3). 
 
The results showed that PI ethanol extract dissolved in DMSO at 0.5, 1 and 2 µg/ml 
protected Neuro-2a cells from the effects of 2 µM acrolein. Also, PL polysaccharides at 10, 20 and 
50 µg/ml and PI ethanol extract dissolved in water at 10, 20 and 50 µg/ml may protect cells from 2 
µM acrolein. PI ethanol extract dissolved in DMSO at 0.5 and 1 µg/ml may protect cells from 5 µM 
acrolein. PL polysaccharides at 50 µg/ml may protect cells from 5 µM acrolein (Fig. 15). These 
observations indicated that the polyphenol extract of P. igniarius greatly reduced the growth 
inhibition of Neuro-2a cells that was caused by acrolein, contrary to earlier results by Kazuei 
Igarishi's group in which acrolein toxicity was not prevented by polyphenols [32]. 
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2.2 The protection of polyphenol extracts on mice stroke model 
 
In the foregoing in vitro experiments we found that PIDMSO (= P. igniarius ethanol extract 
dissolved in DMSO) greatly reduced the inhibition of cell growth induced by acrolein. We therefore 
undertook to measure the effects in vivo using mice with brain infarction photochemically induced 
by Rose Bengal as a model The effects of PIDMSO on brain infarction were examined to confirm 
the correlation between brain infarction and PC-Acro (= protein-conjugated acrolein). Mice were 
injected intraperitoneally with PIDMSO at 200 ng to 20 mg/kg. A brain infarction was photo-
induced after injection of Rose Bengal [77]. The volume of the infarction was determined by 
staining 2 mm thick coronal slices with triphenyltetrazolium. This stains the viable brain tissue red, 
whereas infarct tissue remains unstained [78]. Under our experimental conditions, in which we 
measured the average volume of infarction at 24 hrs after induction of stroke, the average volume 
of infarction decreased from 56.22 mm
3
 to 21.33 mm
3
 and 30.02 mm
3
 from intraperitoneally 
applied PIDMSO at 20 µg/kg and 20 mg/kg, respectively (Fig. 15A). The stroke-induced mice 
treated intraperitoneally with 20 µg/kg PIDMSO showed the highest reduction of infarction 
volume, 62.24%. Furthermore, stroke-induced mice treated intraperitoneally with 200 ng/kg and 2 
µg/kg PIDMSO experienced infarction volume reductions of 5.33% and 14.94%, less than the 
infarction volume reductions with 20 µg/kg to 20 mg/kg PIDMSO (Fig. 17). However, the 
infarction volume reduction did not change significantly with 20 µg/kg, 200 µg/kg, 2 mg/kg and 20 
mg/kg PIDMSO (Fig. 18). 
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Fig. 16. The effect of PIDMSO on a mouse stroke model. The effect of PIDMSO on brain 
infarction size (A), the level of PC-Acro in plasma (B) and the formation of FDP-lys from acrolein 
in protein (C). Experiments were performed using 6 mice in each group as described in Materials 
and Methods. Data are shown as mean ± SE. ***P<0.001 compared with control mice. 
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Fig. 17. The effect of 200 ng/kg and 2 µg/kg PIDMSO on brain infarction size. 
 
 
Fig. 18. The effect of 20 µg/kg and 200 µg/kg PIDMSO on brain infarction size. 
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2.3 Biochemical analysis on mice stroke model 
 
Free acrolein is rapidly converted to PC-Acro through its interaction with lysine side chains 
in proteins (Fig. 16C) [43]. PC-Acro in plasma was measured by the ACR-LYSINE ADDUCT 
ELISA system. The level of PC-Acro in plasma decreased greatly (Fig. 16B) concomitantly with a 
reduction of the infarction. Furthermore, PC-Acro at the locus of brain infarction was measured by 
Western blotting using an antibody against FDP-Lys. PC-Acro (68 kDa) at the locus of the brain 
infarction decreased modestly from intraperitoneal PIDMSO at 20 µg/kg and 20 mg/kg (Fig. 19E).  
 
 
 
Fig. 19. The levels of PC-Acro and albumin in brain tissue. Total proteins (5 µg) from brain tissues 
at the locus of infarction (A,B) and a normal area (C,D) were stained with Coomassie Brilliant Blue 
R250 (A,C), and the relative levels of PC-Acro and albumin were estimated by Western blotting 
using antibodies against mouse albumin (B,D,E). The results represent the mean ± SD of 6 mice. 
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CHAPTER 3 
Characterization and identification of polysaccharides from 
Phellinus linteus and Phellinus igniarius 
 
3.1  Analysis of polysaccharides by High-performance liquid chromatography 
  
  The purified polysaccharides from P. linteus and P. igniarius were semi-quantified for 
monosaccharide composition by GC-MS.  This showed that glucose, galactose and mannose were 
the major components of both. Monosaccharide composition was more accurately determined by 
HPLC as is shown in Table 5. The polysaccharides from P. linteus and P. igniarius contain mainly 
glucose 78.88% and 57.58% respectively with minor proportions of mannose, galactose, xylose, 
arabinose and rhamnose (Fig. 20). Furthermore, these polysaccharides were contain 3-O-Me-
galactose as shown in between peak 1 and peak 2. Yan et al. was reported that P. igniarius contain 
3-O-Me-galactose [80]. Also HPLC analysis showed absence of amino sugar and sulfate groups 
(data not shown indicating that polysaccharides are not contaminated by protein). For P. linteus the 
findings were in close agreement with those of Kozarski et al. [81] who found glucose content of 
84.8 %.  
 
Table 5. Monosaccharide composition of the extracts 
 
Standard 
% sugar of  
P. linteus 
% sugar of  
P. 
igniarius 
Rhamnose 0.82 1.31 
Mannose 8.32 14.51 
Arabinose 1.13 2.63 
Galactose 8.06 20.65 
Xylose 2.80 3.32 
Glucose 78.88 57.58 
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Molecular weight of each of the polysaccharides was determined using HPLC with 
reference to the calibration curve using pullulan standards of known molecular weight (Fig. 21). 
Based on this analysis, polysaccharides from P. linteus and P. igniarius were estimated to be 
20,708 Da and 18,518 Da respectively. 
 
 
 
Fig. 20. The HPLC chromatogram of neutral sugar Mixture of six monosaccharide standard 
(1=Rhamnose, 2=Mannose, 3=Arabinose, 4=Galactose, 5=Xylose, 6=Glucose) (A). The 
composition of monosaccharides in polysaccharides from P. linteus and (B) P. igniarius (C). 
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Fig. 21. The calibration curve using pullulan standards 
 
3.2 The analysis of polysaccharides by Gas chromatography–mass spectrometry  
 
The analysis of partially O-methylated alditol acetates (PMAAs) was carried out as 
described in GC-MS Analysis of Partially Methylated Alditol Acetates [82]. PMAA-GCMS 
patterns obtained from the polysaccharides of P. linteus and P. igniarius were very complex as can 
be seen in Figure 22. The majority of glycosidic linkages are 1→3, 1→6 or 1→ 3,6 from glucose in 
Table 6-7. Polysaccharides have more terminal glucose residues probably related with a relative 
small molecular size. 
 
 
 
25 
 
 
 
Fig. 22. The PMAAs chromatogram of the methylation analysis of polysaccharides from P. linteus 
(A) and P. igniarius (B) obtained by GC-MS.  
 
Table 6. Identification of each peak on GC-MS for methylation analysis of polysaccharide from P. 
linteus  
Peak 
number 
O-methylated 
alditol acetates 
tR 
(min) 
linkage 
type 
Relative 
expression 
1 
 
2,3,4,6-Me4-Manp  
   
24.320 terminal ++ 
2 2,3,4,6-Me4-Glcp 
  
24.979 terminal +++ 
3 2,4,6,-Me3-Glcp 30.090 1, 3 +++++ 
4 2,4,6-Me3-Man-p 30.737 1, 3 ++ 
5 2,4,6,-Me3-Galp 31.225 1, 3 + 
6 2,3,4,-Me3-Manp  32.006 1, 6 +++ 
7 2,3,4,-Me3-Glcp 34.177 1, 6 ++ 
8 2,4-Me-Glcp 39.057 1, 3, 6 +++ 
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Table 7. Identification of each peak by GC-MS for methylation analysis of polysaccharide from P. 
igniarius 
 
Peak 
number 
O-methylated 
alditol acetates 
tR 
(min) 
linkage 
type 
Relative 
expression 
1 2,4,6-Me3-Glcp 29.937 1, 3 ++++ 
2 2,4,6-Me3-Manp 30.694 1, 3 +++ 
3 2,3,4-Me3-Manp 31.926 1, 6 ++ 
4 2,3,4-Me3-Glcp 34.146 1, 6 +++ 
5 2,4-Me-Glcp 38.941 1, 3, 6 ++ 
 
 
3.3  Characterization of polysaccharide by Nuclear magnetic resonance spectroscopy (NMR) 
 
Nuclear magnetic resonance spectroscopy experiments were performed in order to elucidate 
the linkage type of polysaccharides. 1-H and 13-C NMR spectra obtained from each polysaccharide 
show a quite similar pattern even though the monosaccharide compositional analysis of each 
polysaccharide showed its heterogeneity.  The 13-C NMR spectrum  showed six carbon signals at ∂ 
105.34 (C-1) ppm, which correspond to β anomeric carbons, as well as at ∂ 86.70 (C-3), 76.50 (C-
5), 73.10 (C-2), 68.60 (C-4) and 63.58 (C-6) ppm (Fig. 23) corresponding to β-(1→3)-linked 
polysaccharides, which is similar to the spectrum of purified Saccharomyces cerevisiae (1→3)-β-
Glucan [83]. In   addition, there was a small amount of α-glucan present at ∂ 100.55 which was 
similarly found in the spectrum of Agaricus bisporus extract [84]. Several other low intensity 
signals were observed for these polysaccharides that indicated mainly polysaccharide and minor 
mannose content. The 1-H NMR spectra of polysaccharides from P. linteus and P. igniarius are 
shown in Figure 24. The chemical shifts from 1-H NMR and 2D NMR are presented in Table 8-9. 
The two-dimensional COSY, NOESY and TOCSY experiments confirmed these polysaccharides 
have a main chain of →3)-β-D-Glcp-(1→ and →6)-β-D-Glcp-(1→ (Fig. 25-26). In addition, 
NOESY and TOCSY spectra by a short mixing time of NMR experiments showed clearly all of six 
protons of glucose that confirmed that these polysaccharides are relatively small molecules as 
compared with polysaccharide from Tremella fusiformis that was estimated to be 4,600 kDa (data 
not shown). These observations indicated that the polysaccharides from P. linteus and P. igniarius 
are (1→3; 1→6)-β-D-polysaccharides containing some neutral sugar as galactose, rhamnose, 
arabinose, and xylose. In addition, polysaccharide from P. igniarius has a  side chain of α-D-Manp-
(1→ (Fig. 27b). 
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Fig. 23. 13-C NMR spectra of polysaccharides from P. linteus (A) and P. igniarius (B). 
 
 
 
 
Fig. 24. 1-H NMR spectra of Polysaccharides from P. linteus (A) and P. igniarius (B) in D2O at 
30ºC. 
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Table 4. Chemical shifts of Proton and Carbon from P. linteus Polysaccharide. 
 
  1 2 3 4 5 6α 6β 
 PIP  
H-1/  
C-1 
H-2/  
C-2 
H-3/ 
 C-3 
H-4/ 
 C-4 
H-5/  
C-5 
H-
6α/ 
C-6 
H-
6β 
a 
3)-β-D-
Glcp-(1 
4.56/ 
105.34 
3.33/ 
73.10 
3.52/ 
86.70 
3.28/ 
68.60 
3.31/ 
76.50 
3.72/ 
63.57 3.48 
b 
3,6)-β-D-
Glcp-(1 
4.54/ 
105.34 
3.35/ 
72.80 
3.54/ 
85.80 
3.26/ 
68.60 
3.52/ 
75.00 
4.08/ 
68.70 3.58 
c 
β-D-Glcp-
(1 
4.25/ 
105.34 
3.04/ 
73.70 
3.23/ 
76.30 
3.11/ 
70.30 
3.17/ 
76.70 
3.71/ 
61.20 3.71 
 
Table 5. Chemical shifts of Proton and Carbon from P. igniarius Polysaccharide. 
 
  1 2 3 4 5 6α 6β 
 PIP  
H-1/ 
C-1 
H-2/ 
C-2 
H-3/ 
C3 
H-4/ 
C-4 
H-5/ 
C5 
H-
6α/ 
C-6 
H-
6β 
a 
3)-β-D-Glcp-
(1 
4.56/  
105.34 
3.33/ 
72.90 
3.52/ 
86.70 
3.28/ 
68.50 
3.31/ 
76.40 
3.72/ 
63.57 3.48 
b 
3,6)-β-D-
Glcp-(1 
4.54/  
105.34 
3.35/ 
73.00 
3.54/ 
85.80 
3.26/ 
68.25 
3.52/ 
75.0 
4.08/ 
68.70 3.58 
c β-D-Glcp-(1 
4.25/ 
105.34 
3.04/ 
73.40 
3.23/ 
76.30 
3.11/ 
70.30 
3.17/ 
76.6 
3.71/ 
61.2 3.50 
d 
α-D-Manp-
(1 4.98 3.24 3.54 3.26 3.52 n.d. n.d. 
 
n.d., Not detected 
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Fig. 25. The two-dimensional COSY spectra of Polysaccharides from P. linteus (A) and P. 
igniarius (B) in D2O at 30ºC
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Fig. 26. The two-dimensional NOESY and TOCSY spectra of Polysaccharides from P. linteus (A 
and C respectively) and P. igniarius (B and D respectively) in D2O at 30ºC. 
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Fig. 27. Structure of β-polysaccharides from P. linteus (A) and P. igniarius (B)
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CHAPTER 4 
The immunomodulatory effects of polysaccharides from 
Phellinus linteus and Phellinus igniarius 
 
Immunomodulatory activity has been found in many mushroom polysaccharides that have 
been described as (1→3; 1→6)-β-D-polysaccharides [85]. We extracted total RNA from the treated 
cell lines with the RNeasy mini kit. RT-PCR was performed for IL-6, IL-10, and TNF-α; G3PDH 
was used as control as described in Experimental. The mRNA profiles of IL-6 and IL-10 on RAW 
264.7 cell lines are shown in figure 28. The results showed that polysaccharides from P. linteus and 
P. igniarius had no effect on the RAW 264.7 cells, as shown by the G3PDH mRNA profile. 
However, these polysaccharides significantly suppressed IL-6 after proinflammation-induction by 1 
μg/ml LPS for 6 and 24 h (figure 28A). Furthermore, mRNA expression of IL-10 strongly increased 
after 6 h, and then mRNA expression of IL-10 was slightly decreased again after 24 h (figure 28B). 
In addition, both polysaccharides significantly suppressed TNF-α for 6 h (Fig. 29).  
The culture medium of the treated cells was measured using sandwich ELISA kits for IL-6, 
IL-10 and TNF-α as described in Experimental. The results shown in figure 30 clearly indicated 
that at 6 h both polysaccharides significantly decreased TNF-α as compared to the inflammation 
stimulation control, i.e. LPS, (Fig. 30C), and this seemed related with mRNA suppression of TNF-α.  
TNF-α is involved in systemic inflammation where it stimulates the acute phase reaction by 
activated macrophages [86]. The transcription of both TNF-α and of IL-6 slowed within 6 hours 
after exposing the cells to the suppressive activity of the Phellinus polysaccharides. Contrary to the 
reduced secretion of TNF-α in the culture medium (Fig. 30C), IL-6 secretion seemed not to be 
affected in the first 24 hours after addition of the polysaccharides (Fig. 30A). Furthermore, at 6 h 
the polysaccharides induced a very high positive IL-10 response compared to the LPS control. The 
secretion of IL-10 slightly decreased after 24 h which seemed related with the mRNA expression of 
IL-10 (Fig. 30B). LPS treatment caused no strong change of IL-10 production by the macrophages; 
the concentration remained almost identical independent of the extract they were treated with. This 
was different for the transcription values. LPS induced transcription of IL-6 was strongly reduced 
by both Phellinus polysaccharides after both 6 and 24 hours. For IL-10 also Phellinus 
polysaccharides caused reduction of transcription was observed but to a much lower degree than for 
IL-6. The difference between the PCR and ELISA observations could be explained by the relatively 
long time needed for processing and release of (cytokines) proteins compared to the process of 
transcription.  
IL-6 is a pleiotropic cytokine which plays an important pathological role in inflammatory 
and autoimmune diseases. Because of its pro-inflammatory character it also has a significant 
function in the defense against pathogens and cancers. The anti-inflammatory cytokine IL-10 
inhibits the production of  a number of  proinflammatory cytokines such as TNF-α and IL-6 and its 
role has been demonstrated in models of multiple sclerosis (MS), rheumatoid arthritis (RA), 
systemic lupus erythematosus (SLE), diabetes, inflammatory bowel disease (IBD) and other 
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autoimmune diseases [87]. Clinically, a balanced IL-6/IL-10 ratio decreases the risk of chronic 
inflammation and resulting metabolic disorders, and of the mentioned autoimmune diseases [50]. 
Reduced IL-10, a higher IL-6/IL-10 ratio and the absence of a counter-balancing, 
immunoregulatory increase in IL-10 in responses to elevated IL-6 concentrations contribute to the 
pro-inflammatory physiological milieu that is known to be associated with major depression [88], a 
mental health condition in which feelings of sadness, anger, loss and frustration determine daily life 
for a longer period of time. Interestingly, IL-6 has been found to attenuate serotonin 2A receptor 
signalling [89] and is considered an interesting target for treatment of depression [90]. 
We calculated the IL-6/IL-10 ratio as well as the TNF-α/IL-10 ratio for the different 
treatments from our ELISA and PCR data. The TNF-α/IL-10 ratio is considered a parameter of 
chronic inflammation. Table 6 shows that the TNF-α/IL-10 ratios obtained from both the ELISA 
and PCR values are considerably decreased due to the influence of the Phellinus polysaccharides. 
For the IL-6/IL-10 ratio, the PCR data are analogous to the TNF-α/IL-10 ratio. The ELISA data we 
obtained for IL-6/IL-10 ratio decreased after 24 h. These observations suggest Phellinus 
polysaccharides could suppress chronic inflammation, and may reduce inflammation by balancing 
of IL-6/IL-10 ration in immune system. Although, polysaccharides from P. linteus and P. igniarius 
have different composition and structure, their immunomodulatory activity seems very similar.  
This may be because these polysaccharides do have the same main chain and a side chain that is 
recognized  by the  same receptor for immune recognition. 
This study is a novel for polysaccharide from P. linteus and P. igniarius to reduce 
inflammation by ratio in immune system that could provide to investigate the immune system as a 
target for immunoregulatory substances of “medicinal” mushrooms in vivo for the further. 
 
 
Fig. 28. The results of RT-PCR analysis (A) on the mRNA expression of IL-6 (B), IL-10 (C) and 
G3PDH in RAW 264.7 cell line. Cells were treated with LPS 1 μg/ml or with samples,  for 6 and 24 
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h. Statistical analyses were performed by one-way analysis of variance (ANOVA) followed by 
Turkey’s test for selected pairs. The results represent the mean ± SE of duplicate cultures of two 
representative experiments. *p<0.05; **p<0.01; ***p<0.001 versus LPS positive control. 
  
 
Fig. 29. The results of PCR analysis on the mRNA expression of TNF-α and G3PDH in RAW 
264.7 cell line. Cells were treated with LPS 100 ng/ml or samples for 6 h. Statistical analyses were 
performed by one-way analysis of variance (ANOVA) followed by Turkey’s test, for selected pairs. 
The results represent the mean ± SE of duplicate cultures of two representative experiments. 
*p<0.05; **p<0.01; ***p<0.001 versus LPS positive control. 
 
 
 
Fig. 30. Production of IL-6 (A) and IL-10 (B) by the RAW 264.7 cell lines in response to 
polysaccharides from P. linteus and P. igniarius. Cells were treated with LPS 1 μg/ml or samples 
for 6 and 24 h as described in Experimental (C) Production of TNF-α by the RAW 264.7 cell line 
treated for 6 h with LPS 100 ng/ml or samples as described in Experimental. Statistical analyses 
were performed by means of one-way analysis of variance (ANOVA) followed by Turkey’s test, 
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selected pairs. The results represent the mean ± SE (n=3). *p<0.05; **p<0.01; ***p<0.001 versus 
LPS positive control. 
 
Table 10. The ratio of cytokines in RAW 264.7 cells 
  
  mRNA expression ratio   cytokines production ratio 
 TNF-α/IL-10  IL-6/IL10  TNF-α/IL-10  IL-6/IL10 
  6 h   6 h 24 h   6 h   6 h 24 h 
Control 0.713±0.272  n.d. n.d.  0.043±0.003  0.003±0.002 0.001±0.000 
LPS 1.022±0.047  0.996±0.178 0.708±0.259  0.074±0.007  0.023±0.004 0.011±0.001 
PL+LPS 0.622±0.002*  0.333±0.182*** 0.331±0.095*  0.042±0.003  0.024±0.005 0.012±0.001 
PI+LPS 0.681±0.017**  0.172±0.113*** 0.313±0.050**  0.031±0.008  0.018±0.005 0.014±0.000 
 
Values are mean ± SE (n = 4/mRNA expression), (n=3/cytokines production), * p\0.05, ** p\0.01 
and *** p\0.001 versus LPS group 
n.d. not determined
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CONCLUSION 
 
The simple LC-MS method that we described was used to identify the molecular mass of 
the DMSO soluble ethanol extract of P. linteus and P. igniarius fruit bodies in negative mode. The 
polyphenols extract from P. linteus consisted  mainly of 9 compounds that were  3,4-
dihydroxybenzaldehyde, 4-(3,4-dihydroxyphenyl-3-buten-2one, Interfungin A, Inonoblin C, 
Phelligridin D, Interfungin B, Inoscavin E, Inoscavin C and Methylinoscavin D in figure 7. The 
characterization of the different components  was done by assignment of their proton resonances 
that found strong signals of 3,4-dihydroxybenzaldehyde, Interfungin A, Inonoblin C, Phelligridin D, 
Inoscavin E and Inoscavin C.  Furthermore, polyphenol extract from P. igniarius mainly contains 
3,4-dihydroxybenzaldehyde, 4-(3,4-dihydroxyphenyl-3-buten-2one, Inonoblin C, Phelligridin D, 
Inoscavin C, Phelligridin C and Interfungin B in figure 32. In the addition, 
1
H NMR resonances of 
polyphenols were assigned, identifying Inonoblin C, Phelligridin D, Inoscavin C and Phelligridin C. 
We suggest that the difference in the upmentioned biological effects of P. linteus and P. igniarius 
might be caused by the absence respiratory presence of Inoscavin C and Inoscavin D in the extracts. 
In in vitro experiments, we observed that 5 µg/ml and lower concentration PI EtOH extract 
prevented the effects of 2 and 5 µM acrolein, and also could prevent 100 µM H2O2. The results 
showed that PI EtOH extract strongly prevented the effects acrolein and to a higher extent than the 
effects H2O2. The polyphenol extract from P. igniarius greatly reduced the growth inhibition of 
Neuro-2a cells induced by acrolein. The effects of polyphenols from P. igniarius on artificially 
induced brain infarction showed that the average volume of infarction was decreased significantly. 
Furthermore, the concentration of PC-Acro at the locus of brain infarction and in plasma was 
decreased. Our observations suggest that the polyphenols of P. igniarius could serve as a substance 
for new neuroprotective treatment of artificially induced ischemic stroke by scavenging acrolein.   
We determined the composition and structure of polysaccharides isolated from P. linteus 
and P. igniarius by HPLC, GCMS and NMR (1-H, 13-C, COSY, NOESY and TOCSY). The results 
showed that polysaccharides from P. linteus and P. igniarius contain mainly glucose, i.e. 78.88% 
and 57.58% respectively, with minor proportions of mannose, galactose, xylose, arabinose and 
rhamnose. Methylation analyses showed that the majority of glycosidic linkages are   1→3, 1→6 or 
1→ 3,6 from glucose. The two-dimensional COSY, NOESY and TOCSY confirmed these 
polysaccharides to have a main chain of →3,6)-β-D-Glcp-(1→. In addition, polysaccharide from P. 
igniarius showed a side chain of α-D-Manp-(1→. Our observations indicated that these complex 
polysaccharides from P. linteus and P. igniarius are (1→3; 1→6)-β-D-polysaccharides containing 
some neutral sugar as galactose, rhamnose, arabinose, and xylose that have molecular weight 
(20,708 Da and 18,518 Da, respectively). 
 In vitro measurements of immunomodulatory effects by RT-PCR and ELISA showed that 
polysaccharides from P. linteus and P. igniarius significantly decreased TNF-α suggesting immune-
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suppressive activity. Furthermore, these polysaccharides stimulated a highly positive IL-10 
response and strongly suppressed IL-6 and TNF-α mRNA transcription early after LPS treatment. 
In addition, these polysaccharides reduced TNFα/IL-10 and IL-6/IL-10 ratios of the messenger 
RNA’s. These in vitro results suggest that polysaccharides from P. linteus and P. igniarius could 
possibly use in the development of mushroom derivatives that have in vivo anti-inflammatory 
effects. 
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Fig. 31. Structure of polyphenols from P. linteus 
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Fig. 32. Structure of polyphenols from P. igniarius 
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EXPERIMENTAL 
Materials and chemicals 
 
Extraction reagents were purchased from Wako Pure Chemical Industries Ltd. (Tokyo, 
Japan) that are 95% ethanol and Dimethyl sulfoxide (DMSO). The hydrophilic 0.22 µm filters were 
purchased from Merck Ltd. (Tokyo, Japan). Total Phenolics Determination, Phenol reagent solution 
(Acid 1.8 N) was purchased from Nacalai Tesque, Inc. (Kyoto, Japan), and Gallic acid standard 
was purchased from Sigma–Aldrich Co. (Tokyo,Japan). 
Analysis reagents and standard were mostly purchased from Wako Pure Chemical Industries 
Ltd. (Tokyo, Japan), which are Ethanol HPLC grade, Formic acid solution, Acetonitrile HPLC 
grade, Esculetin and 3,4 Dihydroxybenzaldehyde.  
Chromatographic separation was performed on a Hitachi LaChrom Elite HPLC ultra-high-
pressure liquid chromatography (U-HPLC) system from Hitachi High-Technologies Corporation 
(Tokyo, Japan). The chromatographic separation was performed on an Inertsil column (ODS-3 150 
mm × 4.6 mm, 5 μm from GL Sciences Inc., (Tokyo, Japan). Mass spectrum analysis was 
performed using a Bruker amaZon SL Ion Trap Mass Spectrometer from Bruker Japan Co., LTD. 
(Yokohama, Japan) LC-MS Data were collected with Bruker Compass Data Analysis 4.2 from 
Bruker Japan Co., LTD. (Yokohama, Japan). 
NMR experiments were performed by Jeol 600 MHz instrument from JEOL Ltd. (Tokyo, 
Japan). Dimethyl sulfoxide-d6, 99.9% containing 0.05 v/v TMS was purchased from Wako Pure 
Chemical Industries Ltd. (Tokyo, Japan).  
Deionized water used for all the solutions and dilutions was prepared by Milli-Q
®
 Integral 
Water Purification System of Merck Ltd. (Tokyo, Japan). 
Extraction of P. linteus and P. igniarius 
Dried fruiting body powder of wild-type P. linteus and P. igniarius were kindly provided 
by Amazing Grace Health Products Limited Partnership (Bangkok, Thailand). Identification of the 
wild types had been done by Dr. Usa Klinhom (Mahasarakham University, Thailand) and 
representative samples of both species were stored in the collection of the Mushroom Museum of 
said university as published before (Sittiwet & Puangpronpitag, 2008). 
Mushrooms powders from P. linteus and P. igniarius were extracted with 70% ethanol 
(10% w/v) at 70ºC for 16 hrs. The supernatant was removed by centrifugation at 10,000 g for 20 
min. Crude P. linteus (PL EtOH) and P. igniarius (PI EtOH) ethanol extracts were filtered and 
stored at -20ºC for further use. Crude aqueous extracts were prepared by hot water extraction [91] 
for 16 hrs. The P. linteus (PL DDW) and P. igniarius (PI DDW) aqueous extracts were then filtered 
and stored at -20ºC for further use. The P. linteus (PL EtOH) and P. igniarius (PI EtOH) ethanol 
extracts were lyophilized and stored at -20ºC for further use. PI EtOH (PIO) and PL EtOH (PLO) 
powders were dissolved in water, filtered with a hydrophilic 0.22 µm filter, and stored at -20ºC for 
MTT assays. PI EtOH (PIDMSO) and PL EtOH (PLDMSO) powders were dissolved in DMSO, 
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filtered with a hydrophilic 0.22 µm filter, and stored at -20ºC for MTT assays, mouse stroke model 
and analysis. 
After ethanol extraction the tissue was further extracted with hot water [91] for 16 hrs. 
Crude polysaccharides were precipitated by addition of 2.5 volumes of cold 99% ethanol, after 
which the suspension was kept at -20ºC for 16 to 24 hrs. The suspension was then centrifuged at 
15,000 g for 20 minutes. The precipitate was dissolved in a small volume of water and the 
polysaccharides were reprecipitated with alcohol as before for 4-5 times. Ethanol-soluble phenolic 
compounds were removed by a Sep-Pak C18 Plus Light Cartridge. The polysaccharides of P. 
linteus (PLP) and P. igniarius (PIP) were lyophilized and stored at -20ºC for further use. 
 
Total Phenolics Determination 
 
The concentration of total phenols was estimated by the Folin-Ciocalteu assay (Ainsworth 
et al., 2007). The procedure consisted of diluting 50 µl polyphenol extract in 400 µl water followed 
by the addition 50µl of the Phenol reagent solution. The mixture was incubated at room temperature 
for 5 minutes. 500 µl of 7% Na2CO3 Solution was added to the mixture, and then the mixture was 
incubated at room temperature for 90 minutes. Absorbance was measured at 750 nm．Gallic acid 
was used as a standard in concentrations ranging from 0 to 500 μg/ml. 
 
Analysis of polyphenols by liquid chromatography mass spectrometry (LC-MS) 
 
Chromatographic separation was performed on a Hitachi LaChrom Elite HPLC ultra-high-
pressure liquid chromatography (U-HPLC) system fitted with a Bruker amaZon SL Ion Trap Mass 
Spectrometer. The chromatographic separation was performed on an Inertsil column (ODS-3 150 
mm × 4.6 mm, 5 μm). The mobile phase was composed of water (A) with formic acid solution 
(pH=3.0) and 100% acetonitrile (B) with formic acid solution (pH=3.0) under gradient elution 
conditions at 0–60 min, 0–50% B; 60-90 min, 50-100% B and 90-100 min, 100% B. The flow rate 
of the mobile phase was 0.4 ml/min, and the column temperature was maintained at 30ºC. Mass 
spectrum analysis was performed using a Bruker amaZon SL Ion Trap Mass Spectrometer fitted 
with an ESI source and operated in negative ion mode. The key optimized ESI parameters were as 
follows: spray voltage: -3.5 KV; capillary temp: 220ºC; Ultra scan. Data were collected with Bruker 
Compass Data Analysis 4.2 and analyzed by Mass++ software (Tanaka et al., 2014) with the 
MassBank mass spectral library. 
 
Analysis of polyphenols by nuclear magnetic resonance spectroscopy (NMR) 
 
One-dimensional spectra of 10 mg of dry sample exchanged in dimethyl sulfoxide-d6, 
99.9% containing 0.05 v/v TMS was acquired using a Jeol 600 MHz instrument. The operation 
condition for 
1
H NMR was as follows: spin, 15 Hz; relaxation delay, 5 s; temperature, 25ºC. 
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Cell culture for acrolein and H2O2 cytotoxicity 
 
Mouse mammary carcinoma FM3A cells [92] (5×10
4
 cells/ml) were cultured in low glucose 
DMEM (Dulbecco’s modified Eagle’s medium; Nacalai Tesque, Inc., Japan) under 6 conditions: 
control (standard conditions); samples alone at 50, 5 and 0.5 µg/ml; samples with acrolein at 10 
µM, 5 and 2 µM; only acrolein; samples with H2O2 at 200, 150 and 100 µM; and only H2O2 for 24 
and 48 hrs. 
Mouse neuroblastoma cells (Neuro-2a cells) [93] were grown in DMEM culture medium 
(Nacalai Tesque, Inc., Japan) supplemented with 10% fetal bovine serum (Gibco, USA) and 1% 
penicillin-streptomycin mixed solution (Nacalai Tesque, Inc., Japan) at 37°C in 5% CO2 in a 
humidified incubator. Neuro-2a cells (3×10
4
 cells/ml) were plated in 96-well microtiter plates in 
DMEM medium under the standard conditions for 12 hrs. Then, the Neuro-2a cells were treated 
with samples and medium for a control. The activity of the Neuro-2a cells was then measured by 
MTT assay. 
 
Trypan blue assay 
 
Viability of cells was tested in culture fluid with 0.25% trypan blue. After 1 minute the cells 
were counted under a microscope and unstained cells were considered alive. Cell counts were done 
in triplicate. 
 
MTT assay 
 
Cells were plated in 96-well microtiter plates and treated as described above. Thereafter, 
the medium was removed and 50 μl/ml of MTT solution in DMEM and antibiotics (penicillin and 
streptomycin) were added. After a 1 hr incubation, the MTT solution was replaced with 100 μl of 
DMSO to dissolve the tetrazolium crystals. Finally, the absorption was read at a test wavelength of 
540 nm and a reference wavelength of 650 nm with a Multiskan JX microplate reader (Thermo 
Labsystems, UK). Cell viability (%) was calculated as [optical density (OD) of the treated 
wells]/[OD of the control wells] x 100 [94]. 
 
Photochemically Induced Thrombosis Model Mice 
 
All animal experiments were approved by the Institutional Animal Care and Use 
Committee of Chiba University and carried out according to the Guidelines for Animal Research of 
Chiba University. Male C57BL/6NCrSlc mice (8-week-old) were purchased from Japan SLC Inc. 
(Japan). Nine-week-old mice weighing 22 to 27 g were anesthetized with inhalation of 3% 
isoflurane (Abbott, Japan). Anesthesia was continued with 2% isoflurane during the operation. A 
thrombotic occlusion of the middle cerebral artery was induced by a photochemical reaction [95]: 
an incision was made between the left orbit and the external auditory canal, and the temporalis 
muscle was detached from the dura mater to expose the proximal section of the middle cerebral 
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artery. Immediately after intravenous injection of a photosensitizer, Rose Bengal (20 mg/kg), 
through a jugular vein, green light (wavelength: 540 nm) emitted from a xenon lamp (Hamamatsu 
Photonics, Japan) illuminated the middle cerebral artery for 10 min. After middle cerebral artery 
occlusion, the incised skin was restored. At 24 hrs after the induction of photochemically induced 
thrombosis (PIT) stroke, we took blood from the anesthetized mice via the cardiac puncture method. 
After that, the brain was removed and sectioned into 2-mm thick coronal slices. Each slice was 
incubated with 5% triphenyltetrazolium chloride solution at 37°C for 10 min. The volume of the 
infarction was analyzed using ImageJ software [96]. Where indicated, P. igniarius ethanol extract 
dissolved in DMSO (PIDMSO) at 200 ng to 20 mg/kg in phosphate-buffered saline was injected 
intraperitoneally at 0 hr after infarction induction. The experiments were performed using 6 mice in 
each group [97]. 
 
Measurement of PC-Acro 
 
Brain tissues at the locus of infarction in the PIT model mice and at the same locus in 
control mice were homogenized using an Ultra-Turrax homogenizer in 0.5 ml of buffer A 
containing 10 mmol/L Tris/HCl (pH 7.5), 1 mmol/L dithiothreitol, 10% glycerol, 0.2 mmol/L 
EDTA, and 0.02 mmol/L FUT-175 (6-amino-2-naphthyl-4-guanidinobenzoate), a protease inhibitor 
[98]. Total proteins (5 µg) were stained with Coomassie Brilliant Blue R-250 after sodium dodecyl 
sulfate–polyacrylamide gel electrophoresis, and the level of PC-Acro was measured by Western 
blotting [99] using 5 µg of tissue homogenate protein and a polyclonal antibody against bovine 
serum albumin-conjugated acrolein (MoBiTec, Germany). The level of albumin was measured 
similarly using an antibody against bovine serum albumin-conjugated acrolein mouse albumin 
(Bethyl, USA). Relative levels of PC-Acro and albumin were estimated by measuring the density of 
bands of 6 mice with a LAS-1000 imaging analyzer (Fuji film, Japan). Cardiac blood containing 3 
U/ml heparin was centrifuged at 3,000 g for 10 minutes at 4°C. The supernatant (plasma) was 
carefully collected to avoid contamination by erythrocytes. PC-Acro, in which acrolein is converted 
to N
Ɛ
-(3-formyl-3,4-dehydropiperidino-lysine) (FDP-lys) in plasma, was measured by the ACR-
LYSINE ADDUCT ELISA system (NOF Corporation) using 0.05 ml of plasma [100]. After the 
reaction was terminated, absorbance at 450 nm was measured by a Bio-Rad Model 550 microplate 
reader. Protein concentrations were determined by the method of Bradford et al [101]. 
 
Analysis of monosaccharide and Amino sugar composition by HPLC 
 
Polysaccharides (100 µg) were hydrolyzed with 2.5 M trifluoroacetic acid (TFA) at 100ºC 
for 6 h. The aqueous solutions were evaporated to dryness under a N2-stream at 40ºC. The residues 
were dissolved in 100 µl water and analyzed for monosaccharide composition on a HPLC post-
column system with TSK gel Sugar AXI (150×4.6 mm i.d.; Tosoh, Tokyo, Japan). The column 
temperature was kept at 70ºC, equilibrated with 0.5 M Borate buffer (pH 8.5), and flow rate was 0.4 
ml/min. The eluent from the column was combined with 0.5% (w/v) 2-cyanoacetoamide and 1.0 M 
NaOH, both of which were delivered at 0.25 ml/min and heated at 120°C within the reaction loop. 
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Rhamnose, Mannose, Galactose, Glucose, Xylose and Arabinose at 100 ppm were used as standards 
[102].  
         The samples were analyzed for amino sugar composition on a HPLC post-column system 
with TSK gel SCX (150×4.6 mm i.d.; Tosoh, Tokyo, Japan). The column temperature was kept at 
70°C, equilibrated with 0.35 M Borate buffer (pH 7.6), and flow rate was 0.6 ml/min. The eluent 
from the column was combined with 0.5% (w/v) 2-cyanoacetoamide and 1.0 M NaOH, both of 
which were delivered at 2.5 ml/min and heated at 120ºC within the reaction loop. The 
monosaccharide and amino sugars were detected by fluorescence detector with emission at 383 nm 
and excitation at 331 nm. D-glucosamine, D-galactosamine and D-mannosamine at 100 ppm were 
used as standards for amino sugar composition analysis. 
 
Sulfate groups determination  
 
The samples were hydrolyzed as described in analysis of monosaccharide and Amino sugar 
composition by HPLC. The samples were analyzed for Sulfate group determination by HPLC with 
TSK gel IC-Anion-PW (10 µm, 50×4.6 mm i.d.; Tosoh, Tokyo, Japan). The column temperature 
was kept at 45°C, equilibrated with the mixture of 1.42 mM Sodium hydrogen carbonate (NaHCO3) 
and 1.5 mM Sodium carbonate (Na2CO3). The sulfate groups were detected by refractive index 
detector. The flow rate was 0.8 ml/min. Sodium sulfate at 1000, 500, 300, 100, 50 and 10 ppm were 
used as standards. 
 
Analysis of molecular weight by HPLC 
 
The samples were analyzed for molecular weight on HPLC with OHpak SB-806M HQ 
(300×8 mm i.d.; Shodex, New York, America) and refractive index detector. The eluent was 10 mM 
Ammonium bicarbonate (NH4HCO3) with flow rate at 0.5 ml/min. The sulfate groups were detected 
by refractive index detector. The 5,900 to 2,350,000 molecular weights of pullulans were used as 
standards. 
 
Analysis of monosaccharide composition by GC-MS 
 
Polysaccharides were lyophilized and dried in vacuum over P2O5 for 16 h. Polysaccharides 
were hydrolyzed with 1.0 M HCl in MeOH at 80ºC for 24 hours, and 3 times washed by n- hexan. 
Anhydrous pyridine and acetic anhydride were added at room temperature to the lower phases for 
30 minutes and evaporated to dryness under a N2-stream at 40ºC. The methanolyzed 
polysaccharides were trimethylsilylated with 30 ml of a 2:1 (v:v) mixture of N,O-bis (trimethylsilyl) 
trifluoroacetamide (BSTFA)–pyridine at 80°C for 30 minutes [103] in figure 33. The 
trimethylsilylated polysaccharides were then analyzed by GC-MS, and identified by their typical 
retention times and electron impact profiles. Gas liquid chromatography mass spectrometry (GC-
MS) was performed using a Hewlett–Packard model 6890 series II gas chromatograph with Helium 
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as carrier gas. A capillary column (25 m × 0.24 mm i.d.) of Silicone OV-101 held at 280ºC during 
injection and then programmed at 160ºC for 5 min and 160ºC to 260ºC (2ºC/min). 
 
 
Fig. 33. Procedure for composition analysis of polysaccharide by GC-MS 
 
GC-MS Analysis of Partially Methylated Alditol Acetates (PMAAs) 
 
The PMAA strategy involves methylation of all free (non-linkage involved) OH-groups in 
poly- or oligosaccharides using methyl iodide (CH3I) in DMSO at high pH, also known as 
“permethylation”. Polysaccharides 100 µg were dissolved in 200 µl dehydrated DMSO, NaOH-
DMSO (0.2 ml of 50% (w/v) NaOH with 5 ml dehydrated DMSO) and iodomethane 0.1 ml. After 3 
times of sonication for 5 minutes, methylated polysaccharides were extracted by chloroform and 
washed by water. The residues were evaporated to dryness under a N2-stream at 40°C. The dry 
methylated polysaccharides were hydrolyzed with 2.5 M trifluoroacetic acid (TFA) and heated at 
100°C for 4 h. The aqueous solutions were evaporated to dryness under a N2-stream at 40°C. The 
partially methylated sugars were reduced by NaBH4 (5 mg/ml in 30% methanol containing 0.03 M 
NaOH). After removal of borate by evaporation as methyl borate, partially O-methylated alditols 
were acetylated by acetic anhydride [104] in figure 34. The partially methylated alditol acetates 
were analyzed by a Hewlett–Packard model 6890 series II gas chromatograph with a Silicone OV-
101 capillary column (25 m × 0.24 mm i.d.). The analysis was performed in the electron impact 
ionization mode, and an ionizing voltage of 70 eV was used. Several temperature programs were 
investigated from which the best results were obtained at the following gradient: 3 min 100°C, 
4°C/min to 160°C, 0.5ºC/min to 180ºC then 20°C/min to 260°C. 
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Fig. 34. Procedure for methylation analysis of polysaccharides.  
 
Nuclear magnetic resonance spectroscopy (NMR) 
The one-dimensional spectra, on 4-50 mg of dry, exchanged samples in deuterium oxide 
(0.6 ml, 99.9 atom % with 3-(trimethylsilyl) propionic acid-d4 sodium salt (internal standard), were 
performed using a Jeol 600 MHz instrument. The operation conditions for one-dimensional spectra 
were as follows: 1-H NMR; spin, 15 Hz; relaxation delay, 2 s; acquisition, ,1000 scans; temperature, 
 
 
47 
 
30ºC: 13-C NMR; spin, 15 Hz; relaxation delay, 2 s; acquisition, 33,000 scans; temperature, 30ºC. 
The water resonance was suppressed by selective irradiation during the relaxation delay. 
The two-dimensional spectra were obtained by using COSY, NOESY and TOCSY function. The 
operation conditions for two-dimensional spectra were as follows: COSY; spin, 15 Hz; acquisition, 
16 Proton scans; acquisition, 128 COSY scans; temperature, 30ºC: NOESY;mixing time, 150 ms; 
acquisition, 40 Proton scans; acquisition, 40 NOESY scans; temperature, 30ºC: TOCSY; spin, 15 
Hz; acquisition, 16 Proton scans; acquisition, 64 TOCSY scans; spin locking, MLEV17; 
temperature, 30ºC. 
 
Cell culture for immunomodulatory study 
 
The mouse Abelson leukemia virus transformed monocyte macrophage cell line (RAW 
264.7 cell lines) was obtained from Dr. Atsushi Ichikawa. RAW 264.7 cell lines were grown in 
DMEM culture medium (Nacalai Tesque, Inc., Kyoto, Japan) supplemented with 10% Fetal Bovine 
Serum (Life Technology, Tokyo, Japan) and 1% penicillin-streptomycin mixed solution (Nacalai 
Tesque, Inc., Kyoto, Japan), at 37°C in 5% CO2 in a humidified incubator. RAW 264.7 cells 5×10
5
 
cells/ml) were treated in 6-wells polystyrene tissue culture plates with 2 ml cell suspension in each 
well for 24 h. The medium was then removed and replaced by fresh medium containing 
polysaccharides at 100 μg/ml or LPS (100 ng/ml or 1 μg/ml) as proinflammatory controls. After 6 
or 24 h, cells and medium were harvested for further experiments. 
 
Quantitative reverse transcriptase polymerase chain reaction (RT-PCR) analysis  
 
Total RNA was extracted from the treated cell lines with the RNeasy mini kit (Qiagen, 
Valencia, CA, USA) according to the manufacturer’s instructions. cDNA was synthesized in a 20 μl 
reaction mixture with 4 μg of total RNA by using the Blend taq with 10× Buffer for Blend Taq 
(Toyobo Co Ltd., Osaka, Japan) PCR was performed with the PCR Thermal Cycler (Takara Bio Inc. 
Otsu, Japan) and each 2 mM dNTPs (Toyobo Co Ltd., Osaka, Japan) Primer sequences are listed in 
Table 7. The PCR conditions were as follows; G3PDH; 5 min at 95˚C, (30 s at 95°C, 30 s at 60°C 
and 60 s at 72°C) × 30 cycles, and 5 min at, 72°C: IL-6; 5 min at 94˚C, (60 s at 94°C, 120 s at 
61.6°C and 120 s at 72°C) × 30 cycles, and 5 min at 72°C: TNF-α; 5 min at 94°C, (60 s at 94°C, 
130 s at 60°C and 140 s at 72°C) × 30 cycles, and 5 min at 72°C [105]: IL-10; 5 min at 94˚C, (30 s 
at 94˚C, 30 s at 55˚C and 60 s at 72˚C) × 30 cycles, and 5 min at 72˚C [106]. All data were 
normalized to the internal standard G3PDH. 
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Table 11. Primer sequences for PCR. 
 
Gene NCBI 
reference 
Primer sequences (5'-3') Product 
size 
(bp) 
IL-6 NM_031168 
 
F: GTGACAACCACGGCCTTCCCTACT 
R: GGTAGCTATGGTACTCCA 
312 
TNF-α 
 
IL-10 
NM_013693 
 
NM_010548 
 
F:GCGACGTGGAACTGGCAGAAG 
R: GGTACAACCCATCGGCTGGCA 
F: CCAGTTTTACCTGGTAGAAGTGATG 
R: 
TGTCTAGGTCCTGGAGTCCAGCAGACTC 
383 
 
323 
G3PDH  F: GGTATCGTGGAAGGACTCATGAC 
R: ATGCCAGTGAGCTTCCCGTTCAGC 
188 
F, forward primer; R, reverse primer. 
Quantitative determination of cytokines by ELISA 
 
Reactions were carried out by enzyme linked immunosorbent assay (ELISA), using 
eBioscience ELISA Ready-SET-GO (Affymetrix, Tokyo, Japan) for IL-6, IL-10 and TNF-α. Coat 
Corning Costar 9018 ELISA plate with 100 µl/well of capture antibody in Coating buffer was 
sealed and incubated overnight at 4ºC. After incubation, ELISA plates were aspirated well and 
washed 3-5 times with 250 µl/well wash buffer. Then ELISA plates were blocked with 200 µl/well 
of 1×Assay Diluent and incubated at room temperature for 1 h. After that ELISA plates were 
aspirated and washed same as before. After that, 100 µl/well of cell culture medium or standards 
were added and incubated at room temperature for 2 h. After incubation for 2 h, plates were 
aspirated and washed again. Then, 100 µl/well of Avidin-HPR were added and incubated at room 
temperature for 30 minutes. ELISA plates were aspirated and washed 5-14 times. Then, 100 µl/well 
of substrate solution were added at room temperature for 15 minutes and 50 µl of stop solution. 
Absorbance was read at 450 nm in tecan sunrise plate reader A-5082 (Tecan, Tokyo, Japan). Values 
were converted to weight in pg/ml.  
 
Statistics 
Statistical analyses were carried out using GraphPad Prism version 4.0 for Windows 7 
(GraphPad,USA). ANOVA with Tukey's multiple comparison test was applied for multiple 
comparisons. Values are indicated as means ± SE, and significant differences are shown as 
probability values. 
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